Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $0.17 · Revenue $232.56M · 3 analysts
Est. EPS $0.18 · Revenue $238.55M · 2 analysts
Est. EPS $0.51 · Revenue $918.16M · 7 analysts
Est. EPS $0.19 · Revenue $243.36M · 1 analysts
$1.20 per share
$1.20 per share
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $774.6M | +10.2% | +6.4% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $155.6M | +22.8% | -161.6% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +65.0% | -4.0% | +62.9% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +34.1% | -6.8% | -247.2% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +20.1% | +11.5% | -158.0% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $348.6M | +12.3% | -38.3% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +45.0% | +1.9% | -42.0% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 90.4% | +1.3% | -0.5% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 0.56x | -36.3% | +215.4% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $5.5B | +3.6% | -1.4% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 0.64 vs 0.70 | -8.1% | -0.10 vs 0.17 | -159.0% |
| Revenue Surprise | $774.6M vs $744.2M | +4.1% | $235.9M vs $232.6M | +1.4% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Smith Darrin | officer: Executive VP, CIO & Secretary | Common Stock | A | 495 | — |
| Aug 31, 2026 | Malehorn Jeffrey A. | director | Common Stock | A | 791 | — |
| Aug 31, 2026 | Kono Ann | director | Common Stock | A | 791 | — |
| Aug 31, 2026 | KATZMANN LYNNE S | director | Common Stock | A | 791 | — |
| Aug 31, 2026 | FOSTER MICHAEL J | director | Common Stock | A | 791 | — |
Good day, everyone. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sabra Healthcare REIT Second Quarter 2026 Earnings Call. I would now like to turn the call over to Lukas Hartwich, EVP, Finance. Please go ahead, Mr. Hartwich.
Thank you, and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations, including our earnings guidance for 2026 and our expectations regarding our tenants and operators and our expectations regarding our acquisition, disposition and investment plans. These forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2025, as well as in our earnings press release included as Exhibit 99.1 to the Form 8-K we furnished to the SEC yesterday. We undertake no obligation to update our forward-looking statements to reflect subsequent events or circumstances, and you should not assume later in the quarter that the comments we make today are still valid. In addition, references will be made during this call to non-GAAP financial results. Investors are encouraged to review these non-GAAP financial measures as well as the explanation and reconciliation of these measures to the comparable GAAP results included on the Financials page of the Investors section of our website at sabrahealth.com. Our Form 10-Q, earnings release and supplement can also be accessed in the Investors section of our website. And with that, let me turn the call over to Rick Matros, CEO, President and Chair of Sabra Health Care REIT.
Thanks, Lukas, and welcome, everybody to our second quarter earnings call. First, on to investment activity. We closed approximately $600 million in investments, including $100 million in skilled nursing, and we're closing on an additional $100 million in SHOP investments. Our pipeline is as active as it has ever been. The deals that we've done have been closed at attractive yields, and we've got an immense amount of deals that we're looking at, and we were able to remain competitive within the range of deals that we currently announced. Going to operations. Our consolidated, unconsolidated and same-store SHOP cash NOI margins continue to grow. Our triple-net skilled portfolio again shows increased rent coverage as does our top 10 in total. Our triple-net senior housing did show a drop in occupancy and coverage, but that was specifically due to the transition of a high-performing asset from triple net to SHOP. Without that, the results would still be quite strong and essentially flat. We expect Medicaid rates taken together to come in around 2% as rates continue to revert to pre-pandemic levels as …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Richard K. Matros | Chairman, President & Chief Executive Officer | USD 3,526,000 | Male | 1954 | Active |
Michael Lourenco Costa | Executive VP, CFO & Treasurer | USD 1,745,180 | Male | 1979 | Active |
Darrin L. Smith | Chief Investment Officer, Secretary & Executive VP | — | Male | 1969 | Active |
Lukas Michael Hartwich | Executive Vice President of Finance | — | Male | — | Active |
Peter W. Nyland | Executive Vice President of Strategic Initiatives | — | Male | — | Active |
Jessica Flores | Executive Vice President & Chief Accounting Officer | — | Female | 1983 | Active |
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.4 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to FFO of $0.38 per share a year ago.
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2Q26--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2026. SECOND QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2026 were as follows: Net Loss: $(0.10) FFO: $(0.02) Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.40 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.49x Senior Housing - Leased: 1.52x B.
Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Hudson Pacific Properties (HPP) or Sabra Healthcare (SBRA). But which of these two stocks is more attractive to value investors?
First Trust Advisors LP lifted its position in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 99.4% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 750,633 shares of the real estate investment trust's stock after purchasing an additional 374,202 shares during the quarter.
Entropy Technologies LP increased its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 299.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 124,068 shares of the real estate investment trust's stock after acquiring an additional 93,021 shares during
